First Mercantile Trust’s Teva Pharmaceuticals TEVA Stock Holding History

First Mercantile Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,350	Closed	-$771K	–	903
2016 Q2	$771K	Hold	15,350	–	–	0.1%	293
2016 Q1	$821K	Sell	15,350 -7,350	-32%	-$431K	0.1%	264
2015 Q4	$1.49M	Sell	22,700 -30,472	-57%	-$1.88M	0.15%	161
2015 Q3	$3M	Sell	53,172 -4,825	-8%	-$313K	0.3%	77
2015 Q2	$3.43M	Sell	57,997 -6,027	-9%	-$372K	0.29%	79
2015 Q1	$3.99M	Buy	64,024 +7,806	+14%	+$454K	0.33%	72
2014 Q4	$3.23M	Sell	56,218 -26,369	-32%	-$1.47M	0.27%	90
2014 Q3	$4.44M	Buy	82,587 +302	+0.4%	+$16K	0.36%	62
2014 Q2	$4.31M	Buy	82,285 +15,555	+23%	+$795K	0.34%	63
2014 Q1	$3.53M	Sell	66,730 -10,434	-14%	-$482K	0.26%	93
2013 Q4	$3.09M	Sell	77,164 -5,016	-6%	-$198K	0.24%	98
2013 Q3	$3.1M	Buy	82,180 +7,093	+9%	+$277K	0.25%	91
2013 Q2	$2.94M	Buy	+75,087	New	+$2.92M	0.25%	86

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Mercantile Trust's TEVA Position: Q3 2016 in Review

First Mercantile Trust sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 15,350 shares — an estimated $771K sold.

First Mercantile Trust first reported a position in TEVA in Q2 2013 and held it in 13 quarters. The position peaked at $4.44M in Q3 2014. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

First Mercantile Trust reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
First Mercantile Trust sold 15,350 Teva Pharmaceuticals shares in Q3 2016, an estimated $771K.
First Mercantile Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 13 quarters.
First Mercantile Trust's Teva Pharmaceuticals position peaked at $4.44M in Q3 2014.
795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on First Mercantile Trust's 13F filing for Q3 2016, filed 7 Oct 2016.